(Announcement) Notice of President and Board Member Changes
date : 6/30/2014
The Board of Directors of Health and Global Policy Institute (HGPI) held a meeting on June 27, 2014 where it was decided that Mr. Kohei Onozaki will become a board member and the President of HGPI starting on July 1, 2014. Mr. Onozaki previously served as the Vice President of HGPI between 2007 and 2010. He has returned to HGPI to contribute his leadership to the strengthening of HGPI and its activities. The outgoing President, Mr. Hikaru Ishiguro, will continue to contribute to HGPI as a board member.
In regards to Mr. Onozaki’s appointment, the Chairman of HGPI Dr. Kiyoshi Kurokawa remarked, “Kohei Onozaki not only has experience as a leader of this Institute, he brings with him abundant experience from the global corporate world and a wide network of international stakeholders. I am certain that, with his management and public health expertise, Onozaki will contribute to the success of HGPI while strengthening Japanese civil society and serving as a model for non-profit management.”
Additionally, the Commission on Citizens and Health (CCH) ended operations at the end of June 2014. Mr. Kenichi Hanioka resigned as the board member and the head of CCH.
We hope to continue to contribute to cancer control and advocacy policy through HGPI’s Health Policy Unit’s non-communicable disease (NCD) policy projects.
With a renewed structure, we will continue to work to develop and strengthen Japanese civil society. Your continued support of HGPI is sincerely appreciated.
——————————————-
Click here for personal profile of Kohei Onozaki
In regards to Mr. Onozaki’s appointment, the Chairman of HGPI Dr. Kiyoshi Kurokawa remarked, “Kohei Onozaki not only has experience as a leader of this Institute, he brings with him abundant experience from the global corporate world and a wide network of international stakeholders. I am certain that, with his management and public health expertise, Onozaki will contribute to the success of HGPI while strengthening Japanese civil society and serving as a model for non-profit management.”
Additionally, the Commission on Citizens and Health (CCH) ended operations at the end of June 2014. Mr. Kenichi Hanioka resigned as the board member and the head of CCH.
We hope to continue to contribute to cancer control and advocacy policy through HGPI’s Health Policy Unit’s non-communicable disease (NCD) policy projects.
With a renewed structure, we will continue to work to develop and strengthen Japanese civil society. Your continued support of HGPI is sincerely appreciated.
——————————————-
Click here for personal profile of Kohei Onozaki
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)



